# C_2021205EN.01000901.xml

| 31.5.2021 | EN | Official Journal of the European Union | C 205/9 |
| --- | --- | --- | --- |

31.5.2021

EN

Official Journal of the European Union

C 205/9

---

Prior notification of a concentration

(Case M.10202 — EQT/Investindustrial/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 205/07)

1.

This notification concerns the following undertakings:

| — | Igenomix, S.L.U. (‘Igenomix’, Spain), solely controlled by EQT AB (‘EQT’, Sweden); and |
| --- | --- |

—

Igenomix, S.L.U. (‘Igenomix’, Spain), solely controlled by EQT AB (‘EQT’, Sweden); and

| — | Universal Clinics, S.L. (‘Universal Clinics’, Spain), solely controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg). |
| --- | --- |

—

Universal Clinics, S.L. (‘Universal Clinics’, Spain), solely controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg).

The proposed concentration consists of the acquisition of joint control, within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation, of a newly created joint venture (the ‘JV’) by EQT, through Igenomix, and Investindustrial, through Universal Clinics.

The concentration is accomplished by way of purchase of shares.

2.

| — | for EQT: management of investment funds. Portfolio companies controlled by EQT include notably Igenomix, a company dedicated to the business of genetic and molecular diagnostics, as well as clinical and complementary analyses, specialized in the reproductive sector and in vitro fertilisation related testing; |
| --- | --- |

—

for EQT: management of investment funds. Portfolio companies controlled by EQT include notably Igenomix, a company dedicated to the business of genetic and molecular diagnostics, as well as clinical and complementary analyses, specialized in the reproductive sector and in vitro fertilisation related testing;

| — | for Investindustrial: management of investment funds. Portfolio companies controlled by Investindustrial include notably Universal Clinics, a company active in reproduction medicine through the ownership, operation and development of health clinics in Spain, Italy, Czech Republic and Sweden; |
| --- | --- |

—

for Investindustrial: management of investment funds. Portfolio companies controlled by Investindustrial include notably Universal Clinics, a company active in reproduction medicine through the ownership, operation and development of health clinics in Spain, Italy, Czech Republic and Sweden;

| — | for the JV: development and commercialisation of a non-invasive embryo culture medical device to be used by in vitro fertilization laboratories. |
| --- | --- |

—

for the JV: development and commercialisation of a non-invasive embryo culture medical device to be used by in vitro fertilization laboratories.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10202 — EQT/Investindustrial/JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---